Skip to the page

Data / Form D filings / Neuro42, Inc.

Neuro42, Inc.: Form D filings

Neuro42, Inc., a health care company in San Francisco, CA, filed 2 Form D notices with the SEC in 2024. The latest, on September 16, 2024, reports $15.6 million sold of a $36.6 million offering to 85 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
2 BRYANT ST, STE 240, San Francisco, CA, 94105
Phone
(480) 241-3211
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2020
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2026406

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 16, 2024New notice$36,551,492$15,551,687$20,999,80585Sep 4, 2024sec.gov
Jun 11, 2024New notice$7,350,000$6,655,181$694,81924May 29, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Krishna R. BhupalDirector
Amit VohraExecutive Officer, Director
Rahul R. TalwarDirector
Abhita BatraExecutive Officer, Director

Other health care companies in California that filed recently

Every Form D from the week of Sep 16, 2024 · All recent filings in California · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Neuro42, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.